These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9704681)

  • 1. Short- and long-term effects of early fosinopril administration in patients with acute anterior myocardial infarction undergoing intravenous thrombolysis: results from the Fosinopril in Acute Myocardial Infarction Study. FAMIS Working Party.
    Borghi C; Marino P; Zardini P; Magnani B; Collatina S; Ambrosioni E
    Am Heart J; 1998 Aug; 136(2):213-25. PubMed ID: 9704681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post acute myocardial infarction: the Fosinopril in Acute Myocardial Infarction Study (FAMIS).
    Borghi C; Marino P; Zardini P; Magnani B; Collatina S; Ambrosioni E
    Am J Hypertens; 1997 Oct; 10(10 Pt 2):247S-254S. PubMed ID: 9366281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute administration of angiotensin converting enzyme inhibitors in thrombolysed myocardial infarction patients is associated with a decreased incidence of heart failure, but an increased re-infarction risk.
    Voors AA; de Kam PJ; van den Berg MP; Borghi C; Hochman JS; van Veldhuisen DJ; van Gilst WH
    Cardiovasc Drugs Ther; 2005 Mar; 19(2):119-24. PubMed ID: 16025230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The extent of regional wall motion abnormalities identifies patients at risk of extensive left ventricular remodeling: implications for the design of post myocardial infarction trials.
    Zanolla L; Marino P; Golia G; Anselmi M; Zardini P; Borghi C; Ambrosioni E
    G Ital Cardiol; 1999 Jan; 29(1):20-6. PubMed ID: 9987043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of tissue affinity of angiotensin-converting enzyme inhibitors on left ventricular remodeling after myocardial infarction.
    Konermann M; Altmann C; Laschewski F; Josephs W; Odenthal HJ; Horstmann E; Sanner B
    Clin Cardiol; 1998 Apr; 21(4):277-85. PubMed ID: 9562938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of atenolol as add-on therapy to fosinopril in heart failure.
    Pacher R; Hülsmann M; Berger R; Koller-Strametz J; Kos T; Frey B; Dukat A; Stanek B
    Wien Klin Wochenschr; 1997 Apr; 109(7):232-8. PubMed ID: 9141231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Which patient benefits from early angiotensin-converting enzyme inhibition after myocardial infarction? Results of one-year serial echocardiographic follow-up from the Captopril and Thrombolysis Study (CATS).
    van Gilst WH; Kingma JH; Peels KH; Dambrink JH; St John Sutton M
    J Am Coll Cardiol; 1996 Jul; 28(1):114-21. PubMed ID: 8752803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hemodynamic effects of long-term ACE inhibition with fosinopril in patients with heart failure. Fosinopril Hemodynamics Study Group.
    Sharma S; Deitchman D; Eni JS; Gelperin K; Ilgenfritz JP; Blumenthal M
    Am J Ther; 1999 Jul; 6(4):181-9. PubMed ID: 11329095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of L-carnitine administration on left ventricular remodeling after acute anterior myocardial infarction: the L-Carnitine Ecocardiografia Digitalizzata Infarto Miocardico (CEDIM) Trial.
    Iliceto S; Scrutinio D; Bruzzi P; D'Ambrosio G; Boni L; Di Biase M; Biasco G; Hugenholtz PG; Rizzon P
    J Am Coll Cardiol; 1995 Aug; 26(2):380-7. PubMed ID: 7608438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early treatment of acute myocardial infarction with angiotensin-converting enzyme inhibition: safety considerations. SMILE pilot study working party.
    Ambrosioni E; Borghi C; Magnani B
    Am J Cardiol; 1991 Nov; 68(14):101D-110D. PubMed ID: 1746414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators.
    Ambrosioni E; Borghi C; Magnani B
    N Engl J Med; 1995 Jan; 332(2):80-5. PubMed ID: 7990904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefit of converting enzyme inhibition on left ventricular volumes and ejection fraction in patients receiving beta-blockade after myocardial infarction. CONSENSUS II multiecho study group.
    Bonarjee VV; Carstensen S; Caidahl K; Nilsen DW; Edner M; Lindvall K; Snapinn SM; Berning J
    Am Heart J; 1996 Jul; 132(1 Pt 1):71-7. PubMed ID: 8701878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the administration of an angiotensin-converting enzyme inhibitor during the acute phase of myocardial infarction in patients with arterial hypertension. SMILE Study Investigators. Survival of Myocardial Infarction Long-term Evaluation.
    Borghi C; Bacchelli S; Esposti DD; Bignamini A; Magnani B; Ambrosioni E
    Am J Hypertens; 1999 Jul; 12(7):665-72. PubMed ID: 10411363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of early captopril administration after thrombolysis on regional wall motion in relation to infarct artery blood flow.
    French JK; Amos DJ; Williams BF; Cross DB; Elliott JM; Hart HH; Williams MG; Norris RM; Ashton NG; Whitlock RM; McLaughlin SC; White HD
    J Am Coll Cardiol; 1999 Jan; 33(1):139-45. PubMed ID: 9935020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of pravastatin, fosinopril and their combination on myocardium TNF-alpha expression and ventricular remodeling after myocardial infarction in rats].
    Wei M; Gu SM; Zhang YY; Wu YH; Wu ZG
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 May; 33(5):444-7. PubMed ID: 15932706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of combined use of fosinopril and propranolol in acute myocardial infarction].
    Agaev MM; Azizov VA
    Kardiologiia; 2003; 43(2):29-34. PubMed ID: 12891269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fosinopril attenuates clinical deterioration and improves exercise tolerance in patients with heart failure. Fosinopril Efficacy/Safety Trial (FEST) Study Group.
    Erhardt L; MacLean A; Ilgenfritz J; Gelperin K; Blumenthal M
    Eur Heart J; 1995 Dec; 16(12):1892-9. PubMed ID: 8682023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of fosinopril and enalapril in patients with mild to moderate chronic heart failure. Fosinopril in Heart Failure Study Investigators.
    Zannad F; Chati Z; Guest M; Plat F
    Am Heart J; 1998 Oct; 136(4 Pt 1):672-80. PubMed ID: 9778071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the early administration of zofenopril on onset and progression of congestive heart failure in patients with anterior wall acute myocardial infarction. The SMILE Study Investigators. Survival of Myocardial Infarction Long-term Evaluation.
    Borghi C; Ambrosioni E; Magnani B
    Am J Cardiol; 1996 Aug; 78(3):317-22. PubMed ID: 8759812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of enalapril versus captopril on left ventricular function and survival three months after acute myocardial infarction (the "PRACTICAL" study).
    Foy SG; Crozier IG; Turner JG; Richards AM; Frampton CM; Nicholls MG; Ikram H
    Am J Cardiol; 1994 Jun; 73(16):1180-6. PubMed ID: 8203335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.